22 November 2017
News and Views
Links and Services
Rifaximin improves driving performance in patients with minimal hepatic encephalopathy, reports this month's issue of Gastroenterology.
Patients with cirrhosis and minimal hepatic encephalopathy have driving difficulties but the effe
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors